USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name:
CARDAX PHARMACEUTICALS, INC.
Address:
CARDAX PHARMACEUTICALS, INC.
99-193 AIEA HEIGHTS DR, STE 400
AIEA, HI
Phone:
N/A
URL:
N/A
EIN:
120457208
DUNS:
787046437
Number of Employees:
N/A
Woman-Owned?:
No
Minority-Owned?:
No
HUBZone-Owned?:
No

Commercialization:

Has been acquired/merged with?:
N/A
Has had Spin-off?:
N/A
Has Had IPO?:
N/A
Year of IPO:
N/A
Has Patents?:
N/A
Number of Patents:
N/A
Total Sales to Date $:
$ 0.00
Total Investment to Date $
$ 0.00
POC Title:
N/A
POC Name:
N/A
POC Phone:
N/A
POC Email:
N/A
Narrative:
N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $314,438.00 1
SBIR Phase II $944,270.00 1

Award List:

Heptax for Alcoholic Liver Disease

Award Year / Program / Phase:
2009 / SBIR / Phase I
Award Amount:
$314,438.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): Alcoholic Liver Disease (ALD) is caused by excessive long term consumption of alcohol via increased oxidative stress, reduction of oxygen to liver tissue (hypoxia), altered fat metabolism, increased pro-inflammatory sig naling molecules (or cytokines), and… More

Heptax for Alcoholic Liver Disease

Award Year / Program / Phase:
2010 / SBIR / Phase II
Award Amount:
$944,270.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): Alcoholic Liver Disease (ALD) is caused by excessive long term consumption of alcohol via increased oxidative stress, reduction of oxygen to liver tissue (hypoxia), altered fat metabolism, increased pro-inflammatory sig naling molecules (or cytokines), and… More